VIPpharma ApS: Financial statements 2021
CVR: 38744763
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
VIPpharma ApS (CVR 38744763) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 2,076,341 and a net result of DKK 428,487 compared with DKK 715,678 the year before. That is a decrease of 3.5% compared with the year before. Equity in the 2021 report amounted to DKK 2,370,093. The solvency ratio was 76.3%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,076,341
- Profit/Loss
- DKK 428,487
- Equity
- DKK 2,370,093
- Total Assets
- DKK 3,107,482
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 2.1 mio. | 428 t. | 2.4 mio. | 2 |
| 2020 | - | 2.2 mio. | 716 t. | 3.7 mio. | 2 |
| 2019 | - | 1.1 mio. | -173 t. | 3.1 mio. | 2 |
| 2018 | - | 1.5 mio. | 228 t. | 3.4 mio. | - |
| 2017 | - | 1.2 mio. | 760 | 3.2 mio. | - |
Official annual report
Find more companies like VIPpharma ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
VIPpharma ApS has published its annual report for 2020. Gross profit came to DKK 2,150,975, and the net result was DKK 715,678.
About VIPpharma ApS
VIPpharma ApS is a Danish company of the type Anpartsselskab based in Karlslunde, founded in 2017. The company is registered under the industry Public relations og kommunikation. The management consists of Vibeke Wærens. The company is owned by VIPinvest ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 2,432,365 and a net result of DKK 674,851 compared with DKK 1,191,483 the year before. Equity in the 2025 report amounted to DKK 1,263,395.